Panome Bio
PrivateLast Round
Series A
Mar 15, 2023
Total Funding Raised
$6M
Company Overview
Panome Bio is a biotechnology company that provides multi-omics services, including next-generation metabolomics, proteomics, and transcriptomics, to support research in disease and drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Panome Bio Comparables
Compare Panome Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sapient | 88% | |
| Creative Proteomics | 82% | |
| Arome Science Inc. | 80% | |
Panome Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 15, 2023 |
Panome Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioGenerator Ventures | Series A |
| Telegraph Hill Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 25, 2026
Launched MassID, a cloud-based platform for metabolomics data.
Panome Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Panome Bio's valuation, stock price, and market status.